NewsTIF News (DE)

TIF European Thalassaemia & Sickle Cell Disease Symposium To Take Place On 11-13 December 2020

TIF is proudly organising the European Thalassaemia & Sickle Cell Disease Symposium, a joint patients‘ and healthcare professionals‘ three-day educational event which will take place online on 11 – 13 December 2020.

Organised in the context of TIF’s internationally renowned educational programme and the TIF “Thalassemia in Action” (THALIA), co-financed by the Third Health Programme of the European Union, the Symposium is aimed at patients and doctors specialising in the field of haemoglobin disorders, presenting an ideal opportunity for an exchange of knowledge on the latest scientific advances in the field, and for participants to share their concerns and views.

The objectives of the Symposium are to inform the medical and patient communities on the state-of-art clinical management of thalassaemia and sickle cell disease, and to develop the skills and capacities of patients and patients associations. It will also focus on the latest scientific developments in the field, on recent authorisations of new drugs and therapies, and on extending knowledge through sharing experiences.

What’s On The Agenda:

With an agenda that covers the latest advances in research, recent regulatory authorisations of therapies for the care and cure of thalassaemia and sickle cell disease by the European Medicines Agency (EMA), as well as the multidisciplinary care required for appropriate clinical management through case presentations, the Symposium will also deal with topics of major interest concerning patients and their quality of life.

Special focus will be placed on patients’ disease education and the empowerment of patients and their families, whose representation and participation is extremely important at all levels of decision-making bodies, nationally and regionally.

Who Can Participate In The Symposium:

The Symposium will host more than 60 international experts, patients and doctors specializing in haemoglobin disorders, and it is addressed to:

✰ Patients and their families

✰ Patients Associations/Support Groups

✰ Doctors (haematologists, paediatricians, etc.)

✰ Healthcare professionals

✰ Academics and researchers

✰ Policymakers

✰ Industry representatives

Register For Free HERE

View The Full Symposium Programme HERE


Schaltfläche "Zurück zum Anfang"